When South Korean oncology biotechnology company PharmAbcine completed a successful domestic phase I study for the...
You are here
With more than 700 trials completed across most therapeutic areas, Novotech has a world of experience. And it’s that experience that sets us apart, making us one of the leading midsize clinical research organizations – not just in the Asia-Pacific region – but in the world.
Here are just a few examples of why we have a reputation as the leading regional CRO in the Asia-Pacific.
In support of a global registry study, the Thrombosis Research Institute (TRI) engaged Novotech to monitor a...
Our CRO Services
|Regulatory Affairs||Site Management (SMO)|
Our extensive experience as a clinical research organization across major therapeutic areas include:
|Analgesia - pain management||Infectious Diseases - genital herpes, influenza, pneumonia, sepsis|
|Anti-infectives - antivirals, novel antibiotics, vaccines||Gastroenterology - cirrhosis, Crohn's disease, hemorrhoids, IBD|
Cardiovascular - acute coronary syndromes, CAD, CHF, chronic angina
|Oncology - a range of indications including: breast, colorectal, glioma, head & neck, hepatic, melanoma, NSCLC, ovarian, pancreatic, prostate cancer|
|CNS - ADHD, Alzheimer's, epilepsy, migraine, MS, sleep disorders, stroke||Ophthalmology - glaucoma, macular degeneration|
|Dermatology - actinic keratosis, basal cell carcinoma, hyperhidrosis, psoriasis, tinea||Psychiatry - bipolar disease, depression, schizophrenia|
|Endocrinology - diabetes type I and II, HRT, obesity, osteoporosis||Respiratory & Allergy - asthma, bronchitis, cystic fibrosis, emphysema, pneumonia, rhinitis|
|Hematology - CTCL, DVT, leukemia, lymphoma, myeloma, PTCL||Rheumatology - Osteoarthritis and Rheumatoid Arthritis.|